US2020040381A1PendingUtilityA1
Selective oxidation of 5-methylcytosine by tet-family proteins
Est. expirySep 26, 2028(~2.2 yrs left)· nominal 20-yr term from priority
C12Q 1/26C12Q 2537/164G01N 2500/00C12N 2501/71C12N 2501/70C12Q 1/6827G01N 33/5308C12Q 1/6869G01N 33/5011C12Q 1/6806C12Q 2600/154C12N 9/0071C12Q 2521/531C12Q 2522/10C12N 2501/603C12N 15/873C12N 5/0607C12N 2501/15G01N 33/57496C12N 2506/1353C12N 5/0637C12N 5/0018C12N 2506/1307C12N 2501/602G01N 33/57426C12N 2501/604C12N 2510/00C12N 2501/606C12Q 1/6886G01N 33/57484C12N 5/0696C12N 2501/999C12N 2501/724C12N 9/1007
84
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides for novel methods for regulating and detecting the cytosine methylation status of DNA. The invention is based upon identification of a novel and surprising catalytic activity for the family of TET proteins, namely TET1, TET2, TET3, and CXXC4. The novel activity is related to the enzymes being capable of converting the cytosine nucleotide 5-methylcytosine into 5-hydroxymethylcytosine by hydroxylation.
Claims
exact text as granted — not AI-modified1 .- 20 . (canceled)
21 . A method comprising:
(a) obtaining a sample comprising a nucleic acid sequence, wherein said nucleic acid sequence comprises a 5-hydroxymethylcytosine and a 5-methylcytosine; (b) performing a sequencing; and (c) distinguishing said 5-hydroxymethylcytosine from said 5-methylcytosine.
24 . The method of claim 1 , wherein said nucleic acid sequence is a mammalian nucleic acid sequence.
25 . The method of claim 1 , wherein said sample comprises genomic DNA.
26 . The method of claim 1 , wherein said sample comprises an extracellular fluid.
27 . The method of claim 1 , wherein said sequencing is high-throughput sequencing.
28 . The method of claim 1 , wherein said sample is from a subject having or suspected of having cancer.
29 . The method of claim 1 , wherein said distinguishing comprises detecting said 5-hydroxymethylcytosine.
30 . The method of claim 1 , wherein said distinguishing comprises detecting said 5-methylcytosine.
31 . The method of claim 1 , further comprising contacting said nucleic acid sequence with a dioxygenase or catalytically active fragment thereof to convert a methylated cytosine in said nucleic acid sequence to a modified base, wherein said dioxygenase or said catalytically active fragment thereof comprises TET1, TET2, TET3, CXXC4, a catalytically active fragment of any of these, or any combination thereof.
32 . The method of claim 31 , further comprising contacting said nucleic acid sequence with sodium bisulfite.Join the waitlist — get patent alerts
Track US2020040381A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.